Varicose Vein Treatment market is expected to grow from USD 0.26 billion in 2019 to USD 0.43 billion by 2026 at a CAGR of 6.68% from 2020 to 2026.
Varicose veins also referred to as varicosities or varicose is a condition caused due to enlargement of veins. The veins appear blue or dark purple in color and are swollen this condition. A patient affected by varicosities may experience pain due to improper blood flow. The condition generally occurs on legs and feet as an upright position while standing and walking increases the pressure within the veins of the lower body. Furthermore, technological advancement within the devices used for the treatment of veins will spur the varicose vein treatment devices' market growth. The availability of patient-friendly devices with increased efficiency and safety will fuel the demand for such devices. As an example, Medtronic’s VenaSeal closure system is a non-thermal, non-tumescent also as a non-sclerosant procedure that uses a medical adhesive that''s endogenously delivered to shut the vein. this technique eliminates the danger of nerve injury during the treatment of small vena saphead. The development of such devices will upsurge the adoption rate favoring market growth. The global market is segregated on the basis of Treatment Mode as Endovenous Ablation, Injection Sclerotherapy, and Surgical Ligation/Stripping. Based on Product the global market is segmented in Ablation Devices, Radiofrequency Ablation Devices, Laser Ablation Devices, and Venous Closure Products.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Medtronic plc, AngioDynamics, Inc., Biolitec AG, Syneron Medical Ltd., Lumenis Ltd., Dornier MedTech GmbH, Energist Group, Eufoton s.r.l., Vascular Solutions, Inc., Quanta System S.p.A., and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Varicose Vein Treatment market has been segmented as below:
By Treatment Mode
By Product
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers a competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Medtronic plc, AngioDynamics, Inc., Biolitec AG, Syneron Medical Ltd., Lumenis Ltd., Dornier MedTech GmbH, Energist Group, Eufoton s.r.l., Vascular Solutions, Inc., Quanta System S.p.A., and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Endovenous Ablation
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Injection Sclerotherapy
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Surgical Ligation/Stripping
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6.1 Introduction
6.2 Ablation Devices
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Radiofrequency Ablation Devices
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Laser Ablation Devices
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Venous Closure Products
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7.1 Introduction
7.2 Europe
7.2.1 Europe Market, By Treatment Mode
7.2.2 Europe Market, By Product
7.3 North America
7.3.1 North America Market, By Treatment Mode
7.3.2 North America Market, By Product
7.4 Asia Pacific
7.4.1 Asia Pacific Market, By Treatment Mode
7.4.2 Asia Pacific Market, By Product
7.5 Rest of The World
7.5.1 Rest of The World Market, By Treatment Mode
7.5.2 Rest of The World Market, By Product
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9.1 Medtronic plc
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 AngioDynamics, Inc.
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Biolitec AG
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Syneron Medical Ltd.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Lumenis Ltd.
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Dornier MedTech GmbH
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Energist Group
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Eufoton s.r.l.
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Vascular Solutions, Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Quanta System S.p.A.
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The global Varicose Vein Treatment market has been segmented as below:
By Treatment Mode
By Product
By Region
By Company